Kenneth Londoner - Dec 28, 2021 Form 4 Insider Report for BioSig Technologies, Inc. (BSGM)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Kenneth L. Londoner, attorney-in-fact
Stock symbol
BSGM
Transactions as of
Dec 28, 2021
Transactions value $
$0
Form type
4
Date filed
4/25/2022, 05:16 PM
Previous filing
Sep 29, 2021
Next filing
Apr 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSGM Stock Option (Right to Buy) Award $0 +75K $0.00 75K Dec 28, 2021 Common Stock 75K $2.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options shall be fully vested and exercisable as of December 28, 2021, the date of the grant, subject to the terms and conditions of the BioSig Technologies, Inc. 2012 Equity Incentive Plan and the stock option agreement by and between the Company and the reporting person.